HDCN

UPDATED
JUL 31, 2019
channels
end channels
New Users Please Click to Register
Renew or Upgrade your Existing  Account
off UPDATE EMAIL
off CHANGE PASSWORD
off CHECK STATUS
off CHECK PASSWORD
off DISCLOSURE
off PRIVACY
facebook link
HDCN Facebook
off VBOOTHS
off ABOUT OUR SITE
off SYMPOSIA
off FREE ZONE INDEX
off ABSTRACTS
off BY DATE
off BY TOPIC
off SEARCH HDCN
off JOURNALS
off SOCIETIES, LINKS
off CLINICAL TRIALS
calculators
links
off Symposia
Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    Harvard-2018  :  RRI-2018  :  Harvard-2017  :  ISHD-HDU-2017  :  RRI-2017  :  ISHD-HDU-2016  :  RRI-2016  :  ISHD-HDU-2015  :  Brigham-2015  :  RRI-2015  :  ISHD-HDU-2014  :  Brigham-2014  :  ISHD-India-2014  :  RRI-2014  :  Brigham-2013  :  ISHD Shanghai-2013  :  ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-Chicago-2012/14  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
what new
free ISHD Hemodialysis University Chicago (2012-2014)
free ISHD Hemodialysis University Shanghai 2013
free ISHD Hemodialysis University Chicago (2014)
free ISHD Hemodialysis University India (2014)
ishd ISHD Hemodialysis University Chicago (2015)
ishd ISHD Hemodialysis University Chicago (2016)
ishd ISHD Hemodialysis University Chicago (2017) incl. free CME/CEU !


Hoenig  

Harvard Intensive Review of Nephrology 2018   key
Flash or IPAD slide/audio
Harvard Medical School; Boston, MA; August 2018

PART 2

Renal Physiology for the Boards
Melanie P Hoenig MD

(more...)
 

Kotanko  

Kantzow  

Kuhlmann  

Advances in Chronic Kidney Disease 2019   key
Flash or IPAD slide/audio
Renal Research Institute; New Orleans, LA; January, 2019

PART 1

Welcome/Program Overview
Peter Kotanko, MD

Virtual Reality Based Training In Nephrology - Has The Future Arrived
Boris Kantzow, MD

Telemedicine in PD Patients
Martin K. Kuhlmann. MD

Round Table: Is it time to Revise the Categorization of Kidney Disease?

(more...)


articles

Hypertension, Cardiovascular
CV risk of borderline high aldo : renin ratio
Dapagliflozin effects on heart failure
Loop diuretic efficacy and albumin
Antihypertensives in CKD -- pharmacology
Walnut diet good
Adult vs. pediatric HTN guidelines
Nitrates protect vs. salt-induced HTN
BP in CKD: KDIGO controversies
Fournier gangrene with SGLT2 inhibitors
Patent foramen ovale and ischemic stroke
Epagliflozin and heart failure
SGLT2 inhibitors pleotropic effects
DKA in type 1 DM treated with SGLT2 inhib.
Canagliflozin and renal outcomes

CKD, Dialysis
Modeled ingested phosphorus vs. diet data
Poor olfaction ups mortality risk
Viscous fiber supplements good
Atrasentan and renal events in type 2 DM
Low T (testosterone) in dialysis patients
Aquaporin variant and CKD progression
Incremental start and RKF
High-dose vitamin D and (no) stone risk
Kidney tx. in HCV positive recipients
T2 bacterial panel to dx. sepsis
Dialysate potassium and lactate with NxStage
Implantable defibrillators no good in ESRD
AV fistula ligation lowers LVH
Pharmacology of pain management
HD ups circulating microparticles
HD lowers renal perfusion acutely
Short acting ESAs better
Calcium-containing P binders not so bad
Heart failure in CKD (KDIGO)
Dry weight reduction using lung ultrasound
Dietary fiber intake and CV risk in ESRD
Bioimpedance for volume control (review)

Clinical Nephrology
Glucocorticoid induced adrenal insufficiency
Rate of correction of hyPERnatremia
Stem cell tx for refractory lupus
Fruit and veggies to treat CKD acidosis
Sodium zirconmium cyclosilicate and hyperkalemia
New classification of TMA
Empagliflozin in renal transplant pts
Magnesium oxide supplements and CVD
Hyponatremia in dialysis pts (review)




ASN abstracts

key This update's selected ASN 2018 abstracts

Hypertension
Acetazolamide in heart failure; Chronic insomnia and protein-energy wasting; Direct-acting anticoagulants in CKD; Ambulatory BP and renal outcomes in CKD; Diagnosing primary hyperaldosteronism in 2018.

CKD, Dialysis
Risks vs. benefits of anti-platelet agents; Vascular stiffness measurement; Albumin loss with MCO membrane; Comparison of fluid overload indicators; Total IV iron burden and insulin sensitivity; HD effect on platelet function; Dialysate sodium vs. conductivity accuracy; Relative blood volume monitoring and dry weight; PEAK methodology to lower IDWG; Microparticle-based biomarker for HD-induced vascular injury; Chloride increase after CRRT and outcome; Abdominal rectus thickening and PD cath dysfunction; Physical activity; Sarcopenia; Satisfaction scores vs. outcomes; Hospitalization rates affected by remote management; Impact of remote monitoring for PD; Uremic symptoms predict outcome; Urinary biomarkers predict outcome in diabetic nephropathy; Pathology in DN vs. outcome; Body composition vs. outcomes; Citrate dialysate vs. clots and anemia; Metabolic acidosis, chloride, and outcomes in CKD; Citrate in dialysate affects calcium mass balance; Liver stiffness predicts renal outcomes; Duration of anti-platelet Rx with drug-eluting stents in CKD; Low vs. standard dose ACTH test to detect adrenal insufficiency in PD.

Clinical Nephrology, Transplantation
Modeling to guide hyponatremia correction with CRRT; Hyponatremia ups sepsis risk; Urine sodium cutoff to diagnose SIADH; Estimating arterial pH from venous CO2; Delta AG : delta Bicarb ratio in lactic acidosis; Carbonic anhydrase inhibitors in metabolic alkalosis and resp. failure; Patiromer efficacy and safety pooled analysis; Kayexalate and GI events; Tacrolimus trough levels and hypomagnesemia; Anion gap help predict ionized hypocalcemia; Renal biopsy in patients with diabetes and outcomes; PD after renal transplant failure.

 (Kidney Week 2018...)


News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: August 14, 2019 (Aug14)
Aug14 Pretomanid, bedaquiline and linezolid combo FDA approved for resistant TB.
Aug13 SPRINT substudy shows that intensive BP control lowers rate of white matter brain lesions.
Aug13 Dog dies after swim in Georgia lake with blue-green algae bloom
Jul19 Full text of President Trump Executive Order re kidney disease (PDF)
Jul11 Trump's advancing kidney care initiative
Jul11 KidneyX phase 1 winners announced (old news but important - Apr. 29th)
Jul09 Predicing serum K from the EKG trace measured by an Apple watch.
Jul02 HIV infection cured in mice using CRISPR technology.
Jul01 Low grade E. Coli urinary tract infections picked up by DNA testing of urine.
May09 Fournier gangrene of the genitals linked to SGLT2 inhibitor drugs
Apr29 Immune cell test identifies patients with chronic fatigue syndrome.
Apr06 Candida auris infections spreading rapidly across the globe.
Apr03 Rehydrating with soft drinks after exercise increases AKI injury markers
Feb19 Universal flu vaccine on the near horizon
Jan24 Alzheimer disease linked to brain infection by gingivitis bacteria.
Jan12 Bone mass increased by 800% in a mouse model
Jan07 Harvard Intensive Review of Nephrology 2018 now available
Dec11 Randomized PIVOT trial published in NEJM suggests more IV iron is better.
Dec11 Increased mortality with citrate-containing dialysate/HDF fluid in France.
Dec05 Test detects presence of cancer in blood samples based on DNA methylation.
General Advances Emphasis
archive
featured articles
Seminars in Dialysis
key The promise of bioimpedance for volume management in American dialysis patients: An unfulfilled opportunity
Dr. Kotanko discuses various methods volume management, focusing on bioimpedance, which is widely used throughout Europe; in the May/June issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injury Drs. Cottone and Bhamidimarri discuss how conventional tests of liver involvement in hepatitis C need to be interpreted in patients on dialysis; This is one of many articles focusion on HCV diagnosis and treatment in a special Mar/Apr issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key PTH assays in dialysis patients: Practical considerations Drs. Soliman, Hassan, Yaseen and their colleagues review the different type of PTH assays as well as their reliability; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Ultrafiltration rate in conventional hemodialysis: Where are the limits and what are the consequences? Drs. Slinin, Babu, Ishani and their colleagues discuss the evidence that a high UF rate is bad, and also guide us as to what an appropriate target might be; in the Nov/Dec issue of Seminars in Dialysis. (more...)

Hemodialysis
key Online measurement of hemodialysis adequacy using effective ionic dialysance of sodium - a review of its principles, applications, benefits, and risks
Drs. Aslam, Saggi, Salifu, and colleagues discuss the basics of the concept of sodium conductivity monitoring of dialyzer clearance, as well as the potential applications and pitfalls; in the October issue of Hemodial Int (more...)

Seminars in Dialysis
key Vaccination practices in dialysis patients: A narrative review Drs. Kosmadakis and their colleagues guide us regarding what vaccinatinons are officially recommended, vs. others that may simply be a good idea to give; in the Sept/Oct issue of Seminars in Dialysis. (more...)

Hemodialysis
key Management of pain in end-stage renal disease patients: Short review
Drs. Raina, Krishnappa, and Gupta discuss the difficult topic of measuring and managing pain in the context of the current opioid use epidemic in the United States; in the July issue of Hemodial Int (more...)

Seminars in Dialysis
key Beta blockers in patients with end-stage renal disease - Evidence-based recommendations Drs. Weir and Herzog discuss the evidence base regarding when use of beta-blockers may be advantageous in patietns with ESRD, and when one should use alternative medications; in the June issue of Seminars in Dialysis. (more...)

Hemodialysis
key The nature, consequences, and management of neurological disorders in chronic kidney disease
Drs. Jabbari and Vaziri review the numerous way in which neurologic issues can arise in dialysis patients; in the April issue of Hemodial Int (more...)

Seminars in Dialysis
key Business of dialysis and the role of the medical director Dr. Paul Scheel reviews the responsibilities of a dialysis unit medical director are; in the Mar/Apr issue of Seminars in Dialysis. (more...)

Hemodialysis
key Management of hepatitis C virus infection in patients with advanced kidney disease
Dr. Craig Gordon has put together a wonderful supplement dealing with all aspects of hepatitis C virus management in CKD. The articles are open access and free CME and CNE credits are available; in the April issue of Hemodial Int (more...)

Seminars in Dialysis
key When and how can nephrologists treat hepatitis C virus infection in dialysis patients? In a most timely article, Davis, Chute, Chung and their colleagues review the various potential indications for the use of the marvelous new hepatitis C drugs in dialysis patients. in the Jan/Feb issue of Seminars in Dialysis. (more...)

Hemodialysis
key Subcutaneous defibrillators for dialysis patients
In this high-risk population for arrhythmias, it is logical to try the use of subcutaneous defibrillators. Tushar Vachharajani and colleagues review the potential indications as well as problems; in the January issue of Hemodial Int (more...)

 450+
yellow
free   SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

key   ISHD Hemodialysis University (2017-Chicago) -- (2016-Chicago) -- (2015-Chicago) -- (2014-India) -- (2014-Chicago) -- (2013-Shanghai) -- (2012-Chicago)
key   Advances in CKD (Renal Research Institute) (2019) (2018) (2017) (2016) (2015) (2014) (2013) (2012) (2011) (2010) (2009)
free   Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
key   The Harvard Intensive Review of Nephrology (Brigham Renal Board Review) Course: Selected Lectures (2018) -- (2017) -- (2015) -- (2014) -- (2013) -- (2012) -- (2011)
key   American Society of Hypertension (2013)   (2012)   (2011)
key   Renal Physicians Association (2012) (2011) (2010) (2009)
key   American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
free   Fistula First (2010)
key   Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
key   National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
key   American Society for Nephrology Renal Week (2009) (2008) (2007)
key   American Society for Nephrology Board Review Course (2008) (2007)
key   American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
key   Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)

 
 Wiley

 




 
Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

Warning-Disclaimer:
The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Willowbrook, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.com If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com